The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which also identified differences based on sex, age, and timing of onset. Medscape Medical News
Can “Ozempic face,” gastrointestinal distress, and nausea be mitigated? This episode features audio from https://nutritionfacts.org/video/how-to-control-the-side-effects-including-ozempic-face-of-glp-1-drugs/ Visit the video page for all sources and doctor’s notes related to this podcast. https://NutritionFacts.org • Subscribe: https://nutritionfacts.org/subscribe • Donate: https://nutritionfacts.org/donate • Podcast : https://nutritionfacts.org/audio • Books: https://nutritionfacts.org/books • Shop: https://drgreger.org • Facebook: https://www.facebook.com/NutritionFacts.org • Twitter: https://twitter.com/nutrition_facts • Instagram: https://www.instagram.com/nutrition_facts_org
CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans CNBC Novo Nordisk announces that CVS Caremark®, the country’s largest PBM, has decided Wegovy® will be the preferred GLP-1 medicine covered for obesity on its template formularies PR Newswire Eli Lilly shares fall as competitor Novo notches coverage win for … Read more
Top of the morning to you, and a fine one it is. Clear blue skies and pleasant breezes are wafting across the Pharmalot campus, where the official mascots are foraging for their breakfast and rousing the neighbors. This means we are free to focus on the matters at hand — rummaging through our to-do list … Read more
Healthify is banking on the rise of GLP-1 weight-loss drugs in India, integrating them with lifestyle coaching. The firm anticipates strong revenue growth, aiming for a 20% increase, while addressing side-effects and weight maintenance post-treatment.
FAT jabs can treat a liver disease affecting one in five people, a trial found. Semaglutide cut inflammation in two thirds of patients with non-alcoholic fatty liver disease. GettyFat jabs can cut inflammation in two thirds of patients with non-alcoholic fatty liver disease[/caption] Nonalcoholic Fatty Liver Disease (NAFLD) a buildup of fat in the liver … Read more
Researchers in Dallas want to know if the class of drugs, GIP/GLP-1 receptor agonists, might be a secret weapon in the fight against breast cancer.
Results from the ESSENCE Phase III clinical trial published in the New England Journal of Medicine show treating patients with semaglutide can halt and even reverse liver disease.
WEDNESDAY, April 30, 2025 — Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1…
Although biologics are usually given by injection or intravenous infusion, oral formulations might be possible. In general, oral drugs offer many benefits, from simplified distribution to overall cost reductions for patients, as well as being easier use and often have better patient compliance. Nonetheless, acids and enzymes in the stomach can degrade biologics even before … Read more